Journal article 1051 views 135 downloads
The -765G>C Cyclooxygenase-2 Promoter Polymorphism is associated with Type 2 Diabetes Mellitus, Low High-density Lipoprotein and Manifest Angina
,
T Oliver,
SJ Hurel,
SE Humphries,
JW Stephens,
SL Prior,
Sarah Prior
Journal of Diabetes & Metabolism, Volume: 7, Issue: 7
Swansea University Authors:
Rachel Churm , Sarah Prior
-
PDF | Version of Record
Released under the terms of a Creative Commons Attribution License (CC-BY).
Download (342.77KB)
DOI (Published version): 10.4172/2155-6156.1000686
Abstract
Background & Aims: Cycloxygenase-2 (COX-2) catalyses the rate limiting step of prostaglandin biosynthesis. Despite previous studies, it is still unclear whether COX-2 is beneficial or detrimental to cardiovascular risk. The aim of this study was to examine the -765G>C (rs20417) PTGS2 promoter...
| Published in: | Journal of Diabetes & Metabolism |
|---|---|
| ISSN: | 21556156 |
| Published: |
2016
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa50671 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract: |
Background & Aims: Cycloxygenase-2 (COX-2) catalyses the rate limiting step of prostaglandin biosynthesis. Despite previous studies, it is still unclear whether COX-2 is beneficial or detrimental to cardiovascular risk. The aim of this study was to examine the -765G>C (rs20417) PTGS2 promoter gene variant, which encodes COX-2, in relation to markers of cardiovascular risk in a sample of well-characterised subjects with diabetes mellitus. Methods & Results: We observed that the CC genotype was more prevalent in Type 2 diabetes mellitus compared to Type 1 (84.2 vs 15.8%; p≤0.05), and was significantly associated with clinically manifest angina (GG vs GC vs CC: 14.3% vs 15.6% vs 28.0%; p=0.009) and lower HDL-cholesterol levels (GG vs GC vs CC: 1.3mmol/L vs 1.4mmol/L vs 1.2mmol/L; p=0.032). This is in line with previous studies showing that -765G>C genotype variant alters Sp1 binding, resulting in decreased COX-2 activity which is associated with atherosclerosis. Conclusion: We conclude that the CC genotype may contribute to a reduction of prostaglandin E2 mediated insulin secretion, predisposing those individuals to Type 2 diabetes mellitus. Further prospective work is warranted in order to examine the association between COX-2 and cardiovascular risk. |
|---|---|
| Keywords: |
COX-2; polymorphism; Type 2 diabetes; HDL; angina; cardiovascular |
| College: |
Faculty of Medicine, Health and Life Sciences |
| Issue: |
7 |